Inhalation drug product testing
NEW eLearning course
Introduction to pharmaceutical microbiology
Diversity & Inclusion
Insights & resources
Environmental Monitoring (EM) is crucial for drug manufacturers to determine the microbial bioburden within their facility. By taking a proactive approach to monitoring the viable counts in the area and developing a strategy for tackling any contamination, manufacturers can reduce the risk of product contamination and protect patient safety. Moreover, depending on the facility design and specific manufacturing area (e.g. a classified cleanroom), this analysis may be a regulatory requirement.
RSSL are able to consult and assist in recommending an appropriate EM programme schedule, including preparation of Environmental Monitoring Performance Qualification (EMPQ) documentation.
We can also offer a sample processing service to incubate, enumerate and interpret any viable counts observed. Additionally, we provide a microbial identification service, which may assist in root cause analysis and corrective and/or preventive action implementation.
Switchboard: +44 (0)118 918 4000
+44 (0)118 918 4076
We value your trust when sharing your personal data with us. We always treat your data in a fair and respectful manner limited to the purpose above mentioned. If you would like to know more about how we handle your data, please read our privacy notice.